Skip to NavigationSkip to content

News

The therapy demonstrated “a high immune response” against all four serogroups, “consistently across all studies”, showing comparable efficacy and...
According to the proportion of cases in the vaccinated and unvaccinated groups, efficacy was found to be 62% in patients who received two full doses...
Certain Americans could receive a coronavirus vaccine as early as next month, according to Dr Moncef Slaoui, Chief Scientific Adviser for Operation...
The FDA has granted Emergency Use Authorization for Regeneron’s coronavirus antibody treatment which was used to treat President Donald Trump when he...
A New York judge has ordered Johnson & Johnson to pay $120 million to a woman and her husband after she blamed the occurrence of her cancer on...
The World Health Organization does not recommend using Gilead’s antiviral drug remdesivir to treat hospitalised COVID-19 patients, no matter how...
Eli Lilly has entered into a global non-exclusive agreement with Ypsomed for the advancement of an automated insulin delivery system for people with...
The move comes only two days after the release of the final analysis data. Applications to other worldwide regulators will swiftly follow,...
The candidate demonstrated non-inferiority to standard-dose, egg-based quadrivalent-inactivated influenza vaccines in terms of immunogenicity,...
The top ten news stories this week centre around coronavirus vaccine clinical trial results, as Pfizer and BioNTech have backed up their promising...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches